Satellos Bioscience Inc (MSLE)

$11.25 -0.66 (-5.54%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 105,000
Avg Vol 15,576
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 39%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an...

Industry: Biotechnology
Sector: Healthcare
Address:
Royal Bank Plaza, Suite 2800 South Tower 200 Bay Street, Toronto, Canada
Doom_Gloom_AR
Doom_Gloom_AR Mar. 21 at 1:11 AM
$MSLE glad I sold half at 12, riding the free money. We aren't even at half time, keep selling I'll take your shares back.
0 · Reply
topstockalerts
topstockalerts Mar. 19 at 5:33 PM
$MSLE super low liquidity, moves can get exaggerated quickly. Needs careful risk management.
0 · Reply
WBinthehouse
WBinthehouse Mar. 18 at 3:51 PM
$MSLE lol. Where’s all the Bulls with their pump posters. What happened?
0 · Reply
WBinthehouse
WBinthehouse Mar. 18 at 9:14 AM
$MSLE wow 40% off. Maybe 50% today lol. Told you.
0 · Reply
spaceodyssey2001
spaceodyssey2001 Mar. 17 at 10:35 PM
$MSLE
0 · Reply
spaceodyssey2001
spaceodyssey2001 Mar. 16 at 6:30 PM
$MSLE
0 · Reply
McGreggor
McGreggor Mar. 12 at 4:43 PM
$MSLE Is this current dip related to the recent pop in CAPR. Seems like CAPR is finally getting the approval this summer.
1 · Reply
citywokowner
citywokowner Mar. 12 at 3:14 PM
$MSLE Sold half my position, fuck this company. Now im on @WBinthehouse 's side lol. Been holding for years, since ICO days. Nthing but let downs and bleeding. Will be lucky to even recover what I have left in this. For now, GLTA. Enjoy the ride down.
1 · Reply
StreetwiseReports
StreetwiseReports Mar. 11 at 5:43 PM
Analyst Maintains Spec Buy on Biotech After Interim SAT-3247 DMD Data https://ow.ly/aqlp50YsuwO Leede Financial maintained its rating on Satellos Bioscience Inc. ($MSCL.TO; $MSLE:NASDAQ), with a US$16.00 price target following updated interim Phase II SAT-3247 data from the TRAILHEAD trial in Duchenne muscular dystrophy.
0 · Reply
HamBoneXoXo
HamBoneXoXo Mar. 11 at 3:59 PM
$MSLE No firm conviction till full ph2 hits
0 · Reply
Latest News on MSLE
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States

Feb 6, 2026, 8:30 AM EST - 6 weeks ago

Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States

Satellos Bioscience IPO Registration Document (F-10)

Feb 5, 2026, 4:09 PM EST - 6 weeks ago

Satellos Bioscience IPO Registration Document (F-10)

Doom_Gloom_AR
Doom_Gloom_AR Mar. 21 at 1:11 AM
$MSLE glad I sold half at 12, riding the free money. We aren't even at half time, keep selling I'll take your shares back.
0 · Reply
topstockalerts
topstockalerts Mar. 19 at 5:33 PM
$MSLE super low liquidity, moves can get exaggerated quickly. Needs careful risk management.
0 · Reply
WBinthehouse
WBinthehouse Mar. 18 at 3:51 PM
$MSLE lol. Where’s all the Bulls with their pump posters. What happened?
0 · Reply
WBinthehouse
WBinthehouse Mar. 18 at 9:14 AM
$MSLE wow 40% off. Maybe 50% today lol. Told you.
0 · Reply
spaceodyssey2001
spaceodyssey2001 Mar. 17 at 10:35 PM
$MSLE
0 · Reply
spaceodyssey2001
spaceodyssey2001 Mar. 16 at 6:30 PM
$MSLE
0 · Reply
McGreggor
McGreggor Mar. 12 at 4:43 PM
$MSLE Is this current dip related to the recent pop in CAPR. Seems like CAPR is finally getting the approval this summer.
1 · Reply
citywokowner
citywokowner Mar. 12 at 3:14 PM
$MSLE Sold half my position, fuck this company. Now im on @WBinthehouse 's side lol. Been holding for years, since ICO days. Nthing but let downs and bleeding. Will be lucky to even recover what I have left in this. For now, GLTA. Enjoy the ride down.
1 · Reply
StreetwiseReports
StreetwiseReports Mar. 11 at 5:43 PM
Analyst Maintains Spec Buy on Biotech After Interim SAT-3247 DMD Data https://ow.ly/aqlp50YsuwO Leede Financial maintained its rating on Satellos Bioscience Inc. ($MSCL.TO; $MSLE:NASDAQ), with a US$16.00 price target following updated interim Phase II SAT-3247 data from the TRAILHEAD trial in Duchenne muscular dystrophy.
0 · Reply
HamBoneXoXo
HamBoneXoXo Mar. 11 at 3:59 PM
$MSLE No firm conviction till full ph2 hits
0 · Reply
citywokowner
citywokowner Mar. 11 at 2:35 PM
$MSLE Decent recovery from yesterday so far. Lets see if this can hold.
1 · Reply
stevetripp
stevetripp Mar. 11 at 1:01 AM
$MSLE Perfect buying opportunity, Will pickup another 1000 shares tomorrow...
0 · Reply
kiralyi
kiralyi Mar. 10 at 10:29 PM
$MSLE Wow, this one is really volatile. Looks like investors were waiting for functional improvement data. Overall very encouraging presentations, time to buy more at a lower price.
0 · Reply
HamBoneXoXo
HamBoneXoXo Mar. 10 at 9:16 PM
$MSLE I guess that’s what you get for presenting limited data that makes people guessing about efficacy and extent across the dmd population. May be they should have skipped this presentation and waited to get a decent number of patients.
0 · Reply
WBinthehouse
WBinthehouse Mar. 10 at 2:37 PM
$MSLE back to pennies. 12-1 RS with less shares. This drop will be fast and furious no one will know what hit them. lol
1 · Reply
WBinthehouse
WBinthehouse Mar. 10 at 2:33 PM
$MSLE ouch lol
0 · Reply
citywokowner
citywokowner Mar. 10 at 2:32 PM
$MSLE Fucking brutal man.
0 · Reply
WBinthehouse
WBinthehouse Mar. 10 at 2:16 PM
$MSLE going back to Pennie’s. Don’t say you weren’t warned lol
0 · Reply
HamBoneXoXo
HamBoneXoXo Mar. 10 at 2:12 PM
$MSLE Short attack or what?
0 · Reply
WBinthehouse
WBinthehouse Mar. 10 at 2:04 PM
$MSLE lol.. thar she blows
0 · Reply
HamBoneXoXo
HamBoneXoXo Mar. 10 at 1:14 PM
$MSLE Applicability beyond dmd; interesting…
0 · Reply
HamBoneXoXo
HamBoneXoXo Mar. 10 at 1:05 PM
$MSLE Ph2 Trailhead moving along just fine; recruiting continued.
0 · Reply